Dementia, Vascular
-
Subject Areas on Research
- A reevaluation of the duration of survival after the onset of dementia.
- Adult cases of leukoencephalopathy, cerebral calcifications, and cysts: expanding the spectrum of the disorder.
- Apolipoprotein E E4 allele and risk of dementia.
- Apolipoprotein E epsilon 4.
- Association Between Insulin Resistance, Plasma Leptin, and Neurocognition in Vascular Cognitive Impairment.
- Association between APOE epsilon4 allele and vascular dementia: The Cache County study.
- Caregiver-Reported Sleep Disturbances Are Associated With Behavioral and Psychological Symptoms in an Asian Elderly Cohort With Cognitive Impairment-No Dementia.
- Chemotherapy-induced toxic leukoencephalopathy causes a wide range of symptoms: a series of four autopsies.
- Clinical correlates of cognitive decline in vascular dementia.
- Cognitive functioning in Alzheimer's and vascular dementia: a meta-analysis.
- Cytokines and cognition--the case for a head-to-toe inflammatory paradigm.
- Dementia assessment and management.
- Dementia severity and pattern of cognitive performance in vascular dementia.
- Dementia: the leading predictor of death in a defined elderly population: the Cache County Study.
- Diagnostic criteria for vascular cognitive disorders: a VASCOG statement.
- Differences in functional impairment across subtypes of dementia.
- Early recognition of Alzheimer's disease: what is consensual? What is controversial? What is practical?
- Hippocampal volume and incident dementia in geriatric depression.
- Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes.
- Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.
- MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression.
- MRI-defined vascular depression.
- Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging.
- Neuroimaging correlates of dementia rating scale performance at baseline and 12-month follow-up among patients with vascular dementia.
- Neuropsychological correlates of magnetic resonance imaging-defined subcortical ischemic depression.
- Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study.
- Progression of impairment in patients with vascular cognitive impairment without dementia.
- Progression of subcortical ischemic disease from vascular depression to vascular dementia.
- Progressive morphometric and cognitive changes in vascular dementia.
- Protocol for a feasibility randomised controlled trial of Screening and Enhanced Risk management for Vascular Event-related Decline in Memory (SERVED Memory).
- Psychiatric disease in the genomic era: rational approach.
- Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression.
- Recent advances in the genetics of Alzheimer's disease and vascular dementia with an emphasis on gene-environment interactions.
- Regional atrophy of the corpus callosum in dementia.
- Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer's disease.
- Sensitivity of the dementia rating scale in vascular dementia: comparison between two sets of criteria to define cognitive impairment.
- Silent cerebrovascular events and Alzheimer's disease: an overlooked opportunity for prevention?
- The neuropsychological profile of vascular cognitive impairment--no dementia: comparisons to patients at risk for cerebrovascular disease and vascular dementia.
- Vascular dementia: atherosclerosis, cognition and Alzheimer's disease.
- Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study.
- White matter and subcortical gray matter lesion volume changes and late-life depression outcome: a 4-year magnetic resonance imaging study.